Harbin Gloria Pharmaceuticals Co. Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 705.233 million compared to CNY 581.019 million a year ago. Operating income was CNY 37.739 million compared to CNY 783.173 million a year ago. Net income was CNY 21.904 million compared to CNY 658.600 million a year ago. Basic earnings per share from continuing operations was CNY 0.01 compared to CNY 0.2996 a year ago.